Antares Pharma, Inc. (ATRS)

SG&A Expense Growth

10.34%

Quarterly · Period ending:

ATRS logo

ATRS SG&A Expense Growth

Latest reported10.34%
ATRS Quarterly SG&A Growth (QoQ) (0.00% → 10.34%)
High-resolution chart · PNG

ATRS sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
10.3363%
-6.0481%
12.2571%
0.5509%
5.697%
9.369%
5.4194%
-12.0205%
6.8723%
-6.2191%
8.6034%
1.0177%
13.5223%
57.9921%
11.5771%
-4.5164%
6.4869%
-10.3348%
11.2208%
-1.4362%
21.3365%
9.4476%
-19.8386%
-7.7423%
13.8653%
1.0009%
0.0929%
-6.1424%
-3.4014%
6.9748%
-27.1252%
12.587%
18.2888%
59.0271%
51.9436%
8.5584%
-15.9512%
58.4876%
-12.7105%
9.886%
11.9016%
-4.019%
8.3144%
1.1663%
19.9314%
7.8902%
0.8477%
-11.9444%
1.806%
5.8718%
5.7841%
-17.5849%
-16.7188%
18.7495%
-24.6301%
4.3559%
3.3222%
19.4423%
-10.393%
-5.0249%
12.386%
12.1683%
-21.4363%
14.3743%
-10.3582%
63.7752%
-18.441%
-6.0171%
0.7065%
-7.2704%
21.2227%
-9.2048%
-11.2547%
-19.8542%
53.34%
-12.2974%
3.8475%
5.7356%
-7.1983%
9.991%
-27.3296%
16.3897%
7.1258%
13.1634%
468.5198%
-73.5242%
12.1823%
13.6657%
49.0123%
-30.0581%
0%
0%
-31.8945%
14.2019%
12.5%
0%
-7.2012%
7.76%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.